Histone variant H2AX phosphorylation in response to DNA damage is the major signal for recruitment of DNA-damage-response proteins to regions of damaged chromatin. Loss of H2AX causes radiosensitivity, genome instability, and DNA double-strandbreak repair defects, yet the mechanisms underlying these phenotypes remain obscure. Here, we demonstrate that mammalian MDC1/NFBD1 directly binds to phospho-H2AX (gH2AX) by specifically interacting with the phosphoepitope at the gH2AX carboxyl terminus. Moreover, through a combination of biochemical, cellbiological, and X-ray crystallographic approaches, we reveal the molecular details of the MDC1/NFBD1-gH2AX complex. These data provide compelling evidence that the MDC1/NFBD1 BRCT repeat domain is the major mediator of gH2AX recognition following DNA damage. We further show that MDC1/NFBD1-gH2AX complex formation regulates H2AX phosphorylation and is required for normal radioresistance and efficient accumulation of DNA-damageresponse proteins on damaged chromatin. Thus, binding of MDC1/NFBD1 to gH2AX plays a central role in the mammalian response to DNA damage.
INTRODUCTION
DNA double-strand breaks (DSBs) are highly toxic lesions that, if unrepaired or repaired incorrectly, can cause cell death, mutations, and chromosomal translocations and can lead to cancer. Cells react to DSBs by rapidly deploying a host of proteins to the damaged-chromatin regions. Some of these factors engage in DNA repair, while others trigger a signaling pathway (called the DNA-damage checkpoint) that delays cell-cycle progression and coordinates repair processes; together, these events comprise the DNA damage response (DDR). Some DDR factors have intrinsic affinity for free DNA ends, while others, many of which contain BRCA1 carboxy-terminal (BRCT) domains, accumulate in large nuclear aggregates that appear as IR-induced nuclear foci (IRIF) by fluorescence microscopy. Increasing evidence suggests that IRIF are required for accurate and coordinated DSB repair in the context of chromatin.
A key regulator of IRIF formation in mammalian cells is the histone H2A variant H2AX, a component of the nucleosome core structure that comprises 10%-15% of total cellular H2A in higher organisms (Fernandez-Capetillo et al., 2004) . H2AX is phosphorylated extensively on a conserved serine residue at its carboxyl terminus (C terminus) in chromatin regions bearing DSBs, and this is mediated by members of the phosphoinositide-3-kinase-related protein kinase (PIKK) family (Rogakou et al., 1999) . Of these PIKKs, ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) phosphorylate H2AX in response to DSBs in a partially redundant manner (Falck et al., 2005; Stiff et al., 2004) . Cells isolated from H2AX-deficient mice exhibit radiation-induced chromosomal aberrations, indicating that H2AX is involved in the signaling and/or repair of DSBs (Bassing et al., 2002; Celeste et al., 2002) . Indeed, H2AX modulates both homologous recombination (HR) and nonhomologous end joining (NHEJ) pathways of DSB repair, although it is not an essential component of either (Bassing et al., 2002; Celeste et al., 2002; Petersen et al., 2001; Xie et al., 2004) . Interestingly, analysis of complemented H2AX ÿ/ÿ mouse cells showed that replacement of the phosphoacceptor serine residue at the H2AX C terminus with glutamic acid did not rescue the DSB hypersensitivity or IRIF defects of H2AX-deficient cells (Celeste et al., 2003a) . This suggests that phosphorylation of the H2AX C-terminal tail creates an epigenetic signal that is recognized by one or more sensor proteins with specific affinity for the phosphoepitope. Here, we identify the tandem BRCT domain of MDC1/NFBD1 (henceforth named MDC1) as the predominant functional gH2AX phosphorecognition module in mammalian cells.
RESULTS AND DISCUSSION

MDC1 Interacts Directly with gH2AX via Its BRCT Domains
To identify proteins that bind the phosphorylated H2AX C terminus, we designed a phosphopeptide comprising the last 20 C-terminal residues of human H2AX phosphorylated on Ser139. The phosphopeptide and its unphosphorylated derivative were coupled to magnetic beads and used to retrieve (''pull down'') proteins from HeLa nuclear extracts. In contrast to the unphosphorylated peptide, the gH2AX phosphopeptide retrieved several proteins that appeared as predominant bands on an SDS-polyacrylamide gel ( Figure 1A ). Mass spectrometry revealed that the two prominent bands of 250 kDa were MDC1 (the two bands likely represent splice variants), the bands of 150 kDa and 116 kDa were RAD50 and PARP1 respectively, and a somewhat weaker band of 95 kDa was NBS1. While the presence of PARP1 in the pull-downs was not further analyzed, Western blot analyses with antibodies against human MDC1 and members of the MRE11/RAD50/NBS1 (MRN) complex confirmed the existence of these in the H2AX phosphopeptide pull-downs ( Figure 1B ). By contrast, 53BP1, BRCA1, and PTIP-BRCT-domain containing proteins that accumulate in IRIF and colocalize with gH2AX (Manke et al., 2003; Paull et al., 2000; Schultz et al., 2000) -were not efficiently retrieved by the gH2AX phosphopeptide. Furthermore, ATM, DNA-PKcs, and the NHEJ factor Ku70 also did not associate specifically with the gH2AX peptide. Weak association of ATM with the H2AX phosphopeptide was, however, detected in the absence of detergents in the washing buffer (data not shown). This is consistent with our earlier finding that ATM interacts directly with NBS1 (Falck et al., 2005) and that the interaction between ATM and NBS1 is weak in the absence of DNA and is disrupted by low detergent concentrations (Falck et al., 2005; You et al., 2005) . Together with our previous finding that the association of the MRN complex with gH2AX depends on MDC1 (Lukas et al., 2004) , these results indicate that MDC1 is the predominant gH2AX binding protein in nuclear extracts derived from cycling undamaged human cells. MDC1 contains two phosphospecific protein binding domains: an FHA domain at its N terminus and a tandem BRCT domain at its C terminus. However, phosphopeptide pull-down experiments with bacterially expressed GST fusions of these regions showed that only the tandem BRCT domain bound tightly and specifically to the gH2AX phosphopeptide ( Figure 1C ). Consistent with this, only wild-type MDC1 but not an MDC1 mutant lacking the BRCT domains (DBRCT) was retrieved from nuclear extracts of transfected 293T cells ( Figure 1D ). These results thereby establish that MDC1 interacts directly with the gH2AX phosphopeptide via its C-terminal BRCT domains.
By isothermal titration calorimetry (ITC) measurements, we established that the MDC1 BRCT region bound stoichiometrically to a 10 residue phosphopeptide corresponding to the gH2AX C terminus with an affinity of 2.2 mM ( Figure 1E and Table 1 ), similar to previously characterized BRCT-phosphopeptide interactions (Manke et al., 2003; Rodriguez et al., 2003; Yu et al., 2003) . The addition of 6 H2AX residues at (C) Coomassie blue-stained SDS-polyacrylamide gel of an H2AX peptide pull-down experiment using purified GST-fusion fragments of the MDC1 FHA and BRCT domains. (D) Western blot analysis of proteins pulled down by the H2AX peptides from nuclear extracts of full-length GFP-MDC1-transfected 293T cells. Blots were probed with an antibody against GFP. (E) ITC binding isotherms show that the interaction between MDC1 BRCT and H2AX is phosphodependent. Symbols denote the following: d, MDC1 BRCT binding to g-H2AX phosphorylated on Ser139; -, MDC1 BRCT titrated with nonphosphorylated H2AX peptide. (F) Top: the MDC1 tandem BRCT domain binds to C-terminal phosphopeptide motifs. The peptide libraries used were pSer = XXXXpSXXXXXAKKK, pSer-CT = XXXXpSXXX, Ser = XXXXSXXXXXAKKK, pSF = XXXXpSXXFXXAKKK, SF = XXXXSXXFXXAKKK, pThr = XXXXpTXXXXXAKKK, Thr = XXXXTXXXXXAKKK, pSQ = XXXB(pS/pT)QJXXXAKKK, and SQ = XXXB(S/T)QJXXXAKKK. Bottom: the optimal motif of the tandem BRCTs of MDC1. Bar graphs show the relative abundance of each amino acid at a given cycle of sequencing compared to its abundance in the starting peptide library mixture. the peptide's N terminus did not enhance binding (Table 1) , so all further experiments were performed with derivatives of the shorter peptide. Although examination of the H2AX family reveals a second potential PIKK phosphorylation site in mammalian species (Redon et al., 2002) , the doubly phosphorylated peptide bound MDC1 equivalently to the peptide phosphorylated on Ser139 alone (Table 1) . Thus, if Thr136 is phosphorylated in vivo, it is unlikely to significantly affect gH2AX recognition by MDC1. Further analyses revealed that the residue at the pSer +3 position of gH2AX (Tyr142) is critical for MDC1 binding, as its substitution by Ala or Leu completely abrogated detectable binding to the MDC1 BRCT region (Table 1) . Furthermore, the addition of 2 extra Ala residues to the C terminus of the gH2AX peptide dramatically weakened binding (K d > 500mM), indicating that the MDC1 BRCT region is unable to accommodate extra C-terminal residues.
MDC1 Selects a gH2AX-like Motif in Oriented Library Screens
Oriented peptide library screening was used to define an optimal phosphopeptide binding motif for the MDC1 BRCT domain (Yaffe and Cantley, 2000) . All libraries used in our initial experiments failed to bind the MDC1 tandem BRCT region in sufficient quantities for further analysis. These libraries all contained residues C-terminal to the +3 position, so on the basis of the dramatic loss of binding of C-terminally extended gH2AX phosphopeptides described above, we synthesized a new library extending only to the +3 position. This bound MDC1 BRCT in a phosphodependent manner with clear sequence selection in the more C-terminal residues ( Figure 1F ). The resulting motif, S-P/I/V-E/I/V-Y-COOH, is remarkably similar to the H2AX C-terminal sequence (SQEY-COOH). A related motif for the MDC1 BRCT region has been previously obtained from a C-terminally extended library (Rodriguez et al., 2003) , but with additional selection of Phe at the +3 position. Thus, it would appear that the presence of the correct C terminus not only enhances overall binding but also confers a more pronounced Tyr +3 selectivity.
Structure of the MDC1 BRCT-gH2AX Complex
To investigate the molecular basis for MDC1-gH2AX binding, we crystallized the MDC1 tandem BRCT domain with a dualphosphorylated H2AX tail (KKA-pT136-QA-pS139-QEY; although pThr136 is superfluous for MDC1 binding, crystals grew more readily with this version of the peptide). The structure was determined by a single-wavelength anomalous dispersion experiment using selenomethionine-substituted MDC1 BRCT and refined at 2.4 Å , resulting in a crystallographic residual of 19.0% (R free 24.9%) and good stereochemistry (see Figure S1 in the Supplemental Data available with this article online for a segment of the final electron density map and Table S1 for crystallographic statistics). The final model comprises the conserved tandem BRCT domain of MDC1 (residues 1891-2082) and residues 138-142 of gH2AX for each of the two molecules in the asymmetric unit. Residues N-terminal to Ser139 are disordered in the structure, consistent with the absence of significant selection at these positions in the oriented library screens. The 207 residue C-terminal fragment of MDC1 retains the typical tandem BRCT fold (Derbyshire et al., 2002; Joo et al., 2002; Williams et al., 2001) in which each BRCT repeat (BRCT 1 and BRCT 2) adopts a compact a/b fold and is connected by a linker region to form an extended structure 70 Å long and 35 Å in diameter (Figure 2A) . The MDC1 BRCT region shows a conserved and characteristic assembly of the two tandem motifs mediated through extensive interactions between a2 of BRCT 1 and the a1 0 -a3 0 pair of BRCT 2 with the BRCT-linker region. In MDC1, the 26 residue linker adopts a helix-loop-helix structure (aL1 and aL2) and makes contacts with both BRCT 1 and BRCT 2 at the domain interface. aL2 packs against the C terminus of the a2-a1 0 -a3 0 triple-helix bundle, primarily via hydrophobic interactions with a2 and a3 0 , while aL1, which is unique to MDC1, has only limited contacts with the interface. gH2AX binds in an extended conformation to a groove at the interface between the two BRCT repeats, interacting with the b1/a1 loop and the N-terminal ends of a2 and a1 0 (Figure 2A ). Structure and sequence analysis of the MDC1 family reveals that the gH2AX binding groove has been highly conserved throughout evolution ( Figure S2 ). Overall, the structure of the MDC1 BRCT-gH2AX complex explains the requirement for phosphorylation of H2AX Ser139, the overall sequence specificity, and the importance of a free C terminus apparent from our biochemical data ( Figure 2B ; see also below).
A Conserved Phosphobinding Mode in MDC1 and BRCA1
Recent crystallographic and NMR studies have shown how the tandem BRCT domain from BRCA1 binds to phosphopeptides derived from BACH1 (Botuyan et al., 2004; Clapperton et al., 2004; Shiozaki et al., 2004 ) and a library screen . Superposition of the MDC1 BRCTgH2AX structure with our BRCA1-BACH1 structure (Clapperton et al., 2004) results in a rms deviation of 1.8 Å for 146 matched Ca atoms ( Figure S3 ). The overall location of the phosphopeptide is similar in both complexes, and both proteins bind the phosphate moiety through direct interactions with side-and main-chain atoms of three structurally conserved residues: Lys1936, Thr1898, and Gly1899 in MDC1 and Lys1702, Ser1655, and Gly1656 in BRCA1 (Figures 2C and 2D) . Consistent with this, mutation of Lys1936 to Met reduces the affinity of MDC1 for gH2AX to 90 mM as determined by ITC (Table 1) . Even though the tandem BRCT domains of MDC1 and BRCA1 exhibit only 17% sequence identity, the direct protein-phosphate interactions-and even interactions mediated through the solvent lattice-are essentially identical. This extraordinary stereochemical similarity in phosphate binding by two such highly diverged BRCT tandem domains shows that phosphodependent binding is an important and ancient activity of BRCT tandem proteins.
Sequence Specificity of MDC1-gH2AX Binding
Our in vitro peptide library screens and ITC data show a marked selectivity for tyrosine at the +3 position. Tyr142 of gH2AX sits at the interface between the two BRCT repeats, with its phenolic side chain making favorable ringstacking interactions with Pro2009 from a Pro-rich region in the b1 0 -a1 0 loop that is characteristic of MDC1 orthologs ( Figure 2B ). Selection for Tyr rather than Phe is apparently explained by a water-mediated hydrogen-bonding interaction with the side-chain amide group of Gln2008. Of the remaining two H2AX residues involved in the MDC1 interaction, selection for Glu at the pSer +2 position is consistent with the presence of Glu or Asp at this position in known H2AX sequences (Glu141 in human H2AX). Glu141 forms a watermediated contact with Arg1933 via its carboxylate group, van der Waals interactions with Arg1932 and Thr1934, and electrostatic interactions with the basic region around Arg1932 that likely favors acidic side chains at +2 ( Figure 2B ). By contrast, Gln140, which forms part of the consensus ''SQ'' motif for PIKK phosphorylation of H2AX, is the only site that deviates from the H2AX-like motif derived from oriented library screens. Weak selection for Pro +1 may point to a role for MDC1 binding to proline-directed kinase phosphorylation sites in other contexts, although the MDC1 tandem BRCT region binds only very weakly (K d 100 mM) to a phosphopeptide containing a known pSPTF cyclin-CDK motif (data not shown). Regardless, the X-ray structure shows that the Gln +1 side chain is directed away from the MDC1 surface toward bulk solvent. This indicates that the +1 position plays only a minor role in determining MDC1 binding specificity but is instead a crucial determinant of H2AX phosphorylation by PIKKs. Interestingly, a search of human sequences in the SwissProt/TrEMBL databases with a variant of the selected motif S/T-X-E/I/V-Y-COOH (where X is any amino acid) identified only 12 matches. Of these, only 2, H2AX itself (H2AX_HUMAN) and a galactosyltransferase (B3G8_HUMAN) contain Gln +1, and none contain Pro/Ile/Val at this position. Thus, the MDC1 BRCT binding site is tailored to recognize a highly conserved, PIKKphosphorylated C-terminal sequence motif that is rare or even unique in the human proteome.
MDC1 Recognition of the gH2AX C Terminus
The importance of MDC1 specificity to the free pSer +3 C terminus characteristic of all known H2AX sequences is underlined by the adverse effect on binding of C-terminal extensions to the gH2AX phosphopeptide. Our X-ray structure shows that the C-terminal residue, Tyr142, sits above the patch of positive charge generated by MDC1 Arg1933 in the binding cleft ( Figure 2D ). Main-chain interactions between Arg1933 and the peptide are similar to those observed for Arg1699 in previous BRCA1 BRCT phosphopeptide structures. Indeed, the predicted structural homology of these residues has led to the suggestion of a potential role for MDC1 Arg1933 in binding to the H2AX C terminus . Our structure now shows that Arg1933 is indeed crucial to C-terminal recognition, but its interactions with the peptide differ from those made by Arg1699 of BRCA1 in two significant ways (Figure 3) . First, Arg1933 sits higher in the binding cleft due to an altered hydrogenbonding pattern of its terminal amino groups with a conserved Glu (MDC1 2063/BRCA1 1836) located on a3 0 . In addition, the free carboxyl group of the phosphopeptide is rotated with respect to the main-chain amide of the Phe993-Gln994 peptide bond in the BRCA1-BACH1 complex. As a result, Arg1933 of MDC1 is able to form a strong, dual salt-bridging interaction with the negatively charged carboxyl terminus, compared to the single, uncharged hydrogen bond formed by BRCA1 Arg1699 with the BACH1 mainchain carbonyl group. Thus, loss of affinity upon the addition of extra C-terminal residues is attributable to removal of one of the carboxylate oxygen atoms by peptide bond formation and associated loss of negative charge, along with resulting unfavorable changes in the orientation of the Tyr142 side chain with respect to the +3 binding surface.
Conserved Residues within the MDC1 BRCT Region and at the H2AX C Terminus Are Essential for Stable MDC1-gH2AX Association and MDC1 IRIF Formation In Vivo Analysis of the MDC1 BRCT-gH2AX cocrystal structure revealed that 3 residues of BRCT 1 engage in direct hydrogen-bond interactions with gH2AX: Thr1898 and Lys1936 Comparison of the structures of MDC1-gH2AX (top) and BRCA1-BACH1 (bottom) shows a rearranged hydrogen-bonding pattern involving the Arg1933 side chain that optimally presents it to the charged H2AX C terminus. *The side-chain atoms of Gln994 have been removed for clarity.
contact the phosphoserine, and Arg1933 contacts both the peptide backbone and the C-terminal carboxylate group. Significantly, mutation of Arg1933 to Gln (R1933Q) completely abolished detectable phosphopeptide binding by the MDC1 BRCT region, while mutating the two phosphoserine-contacting residues had a less dramatic impact but still significantly decreased binding ( Figure 4A ). The partial defects of the T1898V and K1936M mutants can be explained by a synergistic contribution of both phosphoserine-contacting residues to the overall stability of the complex. However, unlike the situation for the intact BRCT domain, the weak residual phosphopeptide binding activity of the K1936M mutant was insufficient for it to competitively inhibit binding of full-length HeLa cell MDC1 to the gH2AX phosphopeptide ( Figure 4B ). Consistent with the MDC1-gH2AX interaction being important for MDC1 IRIF formation, we found through transient transfection studies that, while full-length MDC1 fused to GFP formed IRIF effectively, the R1933Q and K1936M point-mutated derivatives did not ( Figure 4C ).
Next, we determined the effect of mutating the H2AX C terminus on MDC1 IRIF formation. Consistent with previous reports, we found that H2AX ÿ/ÿ p53 ÿ/ÿ mouse embryonic fibroblasts (MEFs) were defective for MDC1 IRIF formation ( Figure 4D ; Lee et al., 2005; Stewart et al., 2003) . However, while reintroducing a genomic fragment carrying the entire H2AX transcriptional unit (Celeste et al., 2003b) rescued the MDC1 IRIF defect of H2AX ÿ/ÿ p53 ÿ/ÿ MEFs, expression of a H2AX mutant in which the two phosphoacceptor Ser residues were changed to Ala (S136/139A) did not. Interestingly, reintroducing into H2AX ÿ/ÿ p53 ÿ/ÿ MEFs H2AX mutants in which the very C terminus was altered resulted in cell lines with seemingly normal H2AX phosphorylation and gH2AX IRIF formation but with severe defects in MDC1 accumulation. Thus, changing the C-terminal Tyr to Ala (Y142A) led to a complete defect in MDC1 IRIF formation, while extension of the H2AX C-terminal tail by two Ala residues (+AA) significantly reduced the size and intensity of MDC1 IRIF and increased pan-nuclear MDC1 staining ( Figure 4D ). Together, these data show that mutating MDC1 or H2AX in ways that impair the MDC1-gH2AX interaction leads to defects in MDC1 IRIF formation.
Interaction between MDC1 and gH2AX Is Required for Efficient Accumulation of 53BP1, NBS1, and Phosphorylated ATM at Sites of Damaged Chromatin To establish whether the MDC1-gH2AX interaction recruits other DDR factors to regions of damaged chromatin, we created U2OS cell lines carrying stably integrated, tetracyclineregulated expression cassettes directing the expression of wild-type or K1936M mutant MDC1 tandem BRCT derivatives fused to yellow fluorescent protein (YFP). As shown in Figure 5A , and consistent with previous reports (Shang et al., 2003; Xu and Stern, 2003) , overexpression of the wild-type MDC1 BRCT region prevented IRIF formation by MDC1, 53BP1, NBS1, and Ser1981-phosphorylated ATM (ATM activation involves its autophosphorylation on Ser1981, and this autophosphorylated species forms IRIF; Bakkenist and Kastan, 2003) . By contrast, when the K1936M mutant was overexpressed, MDC1, 53BP1, NBS1, and phospho-S1981 ATM formed IRIF in a manner indistinguishable from that in cells not expressing the YFP-BRCT construct (i.e., in noninduced cells; Figure 5A , compare top and bottom panels). Overexpression of the R1933Q mutant also did not affect MDC1, 53BP1, NBS1, and phospho-S1981 ATM IRIF formation (data not shown). Thus, the binding of the isolated MDC1 BRCT region to gH2AX prevents IRIF formation by endogenous MDC1 and also blocks the accumulation of other DDR factors at sites of DNA damage. As a complementary approach to investigate the importance of the MDC1-gH2AX interaction, we exploited our finding that H2AX ÿ/ÿ p53 ÿ/ÿ MEFs stably expressing the H2AX Y142A mutant displayed H2AX phosphorylation and gH2AX IRIF formation but not MDC1 IRIF formation (Figure 4D) . Consistent with previous reports (Celeste et al., 2002; Stewart et al., 2003; Ward et al., 2003) , we found that MDC1, 53BP1, and NBS1 did not form detectable IRIF in H2AX ÿ/ÿ p53 ÿ/ÿ MEFs ( Figure 5B , top panel), whereas they formed normally in H2AX ÿ/ÿ p53 ÿ/ÿ MEFs complemented with wild-type H2AX ( Figure 5B , middle panel). Similarly, the Ser1981-autophosphorylated ATM formed foci in an H2AX-dependent fashion ( Figure 5B ). Strikingly, while gH2AX foci were detected by antibodies in H2AX ÿ/ÿ p53 ÿ/ÿ
MEFs complemented with the Y142A mutant, no IRIF for MDC1, 53BP1, or NBS1 were observed in such cells (Figure 5B, bottom panel) . Furthermore, while ATM autophosphorylation still occurred in H2AX ÿ/ÿ p53 ÿ/ÿ MEFs and in H2AX ÿ/ÿ p53 ÿ/ÿ MEFs complemented with the Y142A mutant of H2AX (data not shown), phosphorylated ATM did not form foci in such cells; instead, weak pan-nuclear staining of phospho-Ser1981 ATM was observed ( Figure 5B , bottom panel). Thus, mutation of H2AX to a form that can still be phosphorylated but no longer binds MDC1 abrogates IRIF formation by all DDR factors studied. The above results establish the MDC1-gH2AX interaction as a critical determinant for IRIF formation. This is perhaps most simply explained for the MRN complex, which interacts directly with MDC1 (Goldberg et al., 2003) . Furthermore, as foci formation by phosphorylated ATM requires interactions between it and the NBS1 C terminus (Falck et al., 2005) , an inability to form MRN IRIF presumably causes defective phospho-ATM foci in cells disrupted for the MDC1-gH2AX interaction. For 53BP1, however, the situation is likely to be more complex as its binding to chromatin at DSB sites is thought to be directed by histone methylation (Huyen et al., 2004) . On the other hand, efficient 53BP1 accumulation at sites of DSBs also requires gH2AX (Celeste et al., 2002; Ward et al., 2003) and a functional MDC1-gH2AX interaction (this study), indicating that binding to methylated histones is not sufficient for 53BP1 IRIF formation. This interpretation is consistent with a recent report identifying MDC1 as a key upstream determinant of the dynamic assembly and sustained retention of 53BP1 at DSB sites (Bekker-Jensen et al., 2005) . Although it remains to be established whether MDC1 influences 53BP1 accumulation through regulation of gH2AX maintenance (Stewart et al., 2003) or by modulating chromatin in a way that permits efficient 53BP1 accumulation, the latter model is attractive because it may explain why low MDC1 expression is sufficient for seemingly normal 53BP1 accumulation at early time points after damage induction ( Figure S4 ; Goldberg et al., 2003; Mochan et al., 2003; Peng and Chen, 2003) while deletion of H2AX or abrogation of the MDC1-gH2AX interaction prevents 53BP1 accumulation.
The MDC1-gH2AX Interaction Is Needed for Normal Radioresistance but Not for Activation of the Intra-S Phase Checkpoint To explore the physiological role (or roles) of the MDC1-gH2AX interaction, we used the systems developed above in which the interaction was abrogated by overexpression of the MDC1 BRCT region or by H2AX mutations. Significantly, colony-survival analyses after IR treatment revealed that overexpression of the MCD1 BRCT domains rendered human U2OS cells radiosensitive ( Figure 5C , left graph), whereas overexpression of the K1936M mutant did not (data not shown; we chose the K1936M and not the R1933Q mutant as a negative control because it is structurally neutral, while Arg1933 plays an important structural role in BRCT tandem domains through interactions with the C-terminal helix a3 0 ). Furthermore, while transfection with a vector expressing wild-type H2AX effectively rescued the radiosensitivity of H2AX ÿ/ÿ p53 ÿ/ÿ MEFs ( Figure 5C , right graph), expression of the H2AX Y142A mutant yielded an intermediate phenotype: much less resistant than cells expressing wildtype H2AX, but somewhat more resistant than noncomplemented H2AX ÿ/ÿ p53 ÿ/ÿ MEFs. These results demonstrate that, while additional MDC1-independent functions for gH2AX cannot be excluded, a functional MDC1-gH2AX interaction is crucial for normal radioresistance in both p53-positive human U2OS cells and p53-deficient mouse cells.
As decreased radioresistance can indicate a defect in DSB repair, we tested whether disruption of the MDC1-gH2AX interaction interfered with DSB rejoining. While we did not detect a significant DSB repair defect in YFP-BRCToverexpressing cells when we analyzed them by pulsedfield gel electrophoresis (data not shown), YFP-BRCToverexpressing cells-but not cells overexpressing the K1936M mutant-had a dramatic defect in random plasmid integration ( Figure 5D ; YFP-BRCT overexpression did not reduce cell survival or plating efficiency in the absence of exogenous DNA damage, data not shown). These findings are consistent with a recent report showing that depletion of MDC1 by siRNA reduced random-plasmid-integration frequency in human cells (Lou et al., 2004) and indicate that, while not essential for NHEJ, the MDC1-gH2AX interaction is required for a subset of DNA end-joining events.
When damaged by IR during S phase, mammalian cells transiently reduce DNA synthesis in a manner partially dependent on MDC1 but independent of H2AX (Celeste et al., 2002; Goldberg et al., 2003; Lou et al., 2003; Stewart et al., 2003) . This suggests that MDC1 influences the intra-S phase checkpoint through a mechanism that does not depend on its interaction with gH2AX. Indeed, cells overexpressing the YFP-BRCT fusion construct of MDC1 displayed even more efficient reduction of DNA synthesis after irradiation than noninduced control cells ( Figure 5E, left graph) . Furthermore, when the inducible U2OS cells were depleted of endogenous MDC1 by siRNA transfection, they displayed a partial defect in IR-induced reduction of DNA synthesis regardless of whether or not they overexpressed the YFP-BRCT construct ( Figure 5E , right graph). These results confirm that regulation of the intra-S phase checkpoint by MDC1 is mechanistically distinct from its gH2AX binding function. In this context, it is interesting to note that overexpression of the MDC1 FHA domain triggers a pronounced intra-S phase checkpoint defect (Goldberg et al., 2003) . The FHA domain of MDC1 does not bind to gH2AX ( Figure 1C ), but it interacts with the MRN complex (Goldberg et al., 2003) . Thus, it is possible that MDC1 is composed of at least two functionally distinct regions, each carrying a phosphodependent protein interaction module: the N-terminal region that contains the FHA domain may control crosstalk between MDC1 and the MRN complex to mediate checkpoint activation, whereas the C-terminal BRCT region is required for sustained interactions with gH2AX to form IRIF that facilitate efficient DSB repair.
MDC1 Controls H2AX Phosphorylation by Two Synergistic Mechanisms
Although it has been proposed that MDC1 is involved in the regulation of H2AX phosphorylation (Stewart et al., 2003) , it is not known whether MDC1 controls initial H2AX phosphorylation, gH2AX maintenance, or both. To address this issue, we created a U2OS cell line containing a stably integrated MDC1-targeting small hairpin RNA (shRNA) expression cassette that silenced MDC1 expression with high efficiency (see Figure S4A) ; we then examined these and control cells for H2AX phosphorylation in response to IR ( Figure 6A ). Consistent with earlier findings (Rogakou et al., 1998) , in control cells expressing a LacZ-targeting shRNA, H2AX phosphorylation levels reached a maximum 10 min after IR treatment, started to decline between 1 and 2 hr, and reached background levels 8 to 12 hr postirradiation. Notably, in MDC1-depleted cells, the initial H2AX phosphorylation was similar to that in control cells, but it then declined much more rapidly than in control cells and had already reached background levels between 4 and 8 hr after damage induction. Thus, downregulation of MDC1 expression to low levels does not prevent gH2AX formation but instead impacts on gH2AX maintenance.
One explanation for the above observation is that MDC1 may protect gH2AX from premature dephosphorylation by physically preventing access to the phospho-Ser139 site by phosphatases. Consistent with this idea, a purified GST fusion containing the MDC1 tandem BRCT domain prevented l-phosphatase from dephosphorylating a gH2AX phosphopeptide in vitro, whereas the K1936M mutant protein did not ( Figure 6B ). Also supporting a role for MDC1 in regulating gH2AX dephosphorylation, we found that U2OS cells expressing the MDC1 tandem BRCT domain-YFP fusion displayed higher levels of H2AX phosphorylation than control cells ( Figure S5B ). Furthermore, pan-nuclear background gH2AX staining was generally observed in YFP-BRCT-expressing cells, and the intensity of this staining correlated with the extent of YFP-BRCT overexpression (Figure S5C) . Although the mechanism of gH2AX removal in mammalian cells is not yet understood and the phosphatase responsible for dephosphorylation of Ser139 has yet to be identified, these findings suggest that one mechanism by which MDC1 regulates gH2AX maintenance involves its control of gH2AX dephosphorylation.
It has recently been demonstrated that MDC1 undergoes a dynamic exchange between the chromatin flanking the sites of DSBs and the neighboring nucleoplasm, with the mean residence time at the damage sites of only 6.7 s (Lukas et al., 2004) . Such a rapid exchange is likely to provoke repeated phosphorylation/dephosphorylation cycles of H2AX in damaged-chromatin regions. Thus, another way that MDC1 might influence gH2AX maintenance is by controlling ATM activity (Mochan et al., 2003) . However, when we analyzed cells 1 hr after IR treatment, MDC1 depletion had no discernible effect on ATM Ser1981 phosphorylation or the phosphorylation state of several known ATM target proteins (CHK2, NBS1, SMC1, and p53), indicating that MDC1 depletion does not impair ATM activity per se ( Figure S5A ). Nevertheless, and consistent with data obtained in cells overexpressing the MDC1 BRCT region, MDC1 depletion led to consistent defects in IRIF formation by phospho-Ser1981 ATM ( Figure 6C ; this shows a mixed population of cells containing either a LacZ shRNA or an MDC1 shRNA, and ATM phospho-Ser1981 foci exist in the former but not the latter). These findings raised the possibility that MDC1 might influence H2AX phosphorylation by retaining active ATM (B) In vitro phosphatase protection assay. H2AX phosphopeptide was preincubated with GST and GST-BRCT fusion protein as indicated for 10 min at room temperature, followed by addition of l-phosphatase and incubation at 30ºC for 30 min. SDS gel loading buffer was added, and the reaction was stopped by heating to 95ºC. Increasing amounts of reaction products were spotted on nitrocellulose, followed by phosphopeptide detection with a specific phospho-S139 H2AX antibody. (and perhaps also DNA-PK) in damaged-chromatin regions. Since MDC1 is vital for the accumulation of active ATM on damaged chromatin, it is conceivable that the local concentration of active ATM at sites of damage mediated by MDC1 may shift the equilibrium of H2AX phosphorylation/dephosphorylation toward phosphorylation. For such a model to explain the premature loss of H2AX phosphorylation upon loss of the MDC1-gH2AX interaction, we reasoned that continual ATM and DNA-PK activity would be needed for maintaining normal H2AX phosphorylation. To test this, we treated cells with IR, incubated them for 10 min to allow H2AX phosphorylation, and then treated or mock treated them with smallmolecule inhibitors of ATM and DNA-PKcs. While H2AX phosphorylation was maintained for several hours in the mock-treated cells, it was rapidly lost in the inhibitor-treated cells ( Figure 6D ; similar results were obtained with other PIKK targets such as CHK2 and SMC1; J. Falck, personal communication) . This reveals that continued PIKK activity is required for normal gH2AX maintenance and suggests that MDC1-mediated PIKK accumulation promotes normal gH2AX maintenance. In addition, comparison of H2AX phosphorylation levels in wild-type and Y142A-complemented H2AX ÿ/ÿ p53 ÿ/ÿ MEFs that expressed comparable amounts of total H2AX revealed significantly lower levels of H2AX phosphorylation in Y142A-complemented cells (Figure S5E ). Based on these results, we suggest that MDC1 contributes to normal H2AX phosphorylation after IR both by protecting gH2AX from phosphatases and by promoting H2AX phosphorylation through its mediation of the retention of active ATM, and possibly also DNA-PK, in damaged-chromatin regions. It has so far not been possible to distinguish between the relative contributions of these mechanisms because disruption of the MDC1-gH2AX interaction or depletion of endogenous MDC1 interferes with both processes.
Conclusions
We have presented biochemical, biological, and structural evidence indicating that MDC1 is the predominant gH2AX recognition module in higher eukaryotes. Firstly, we demonstrate that the BRCT tandem domain of MDC1 interacts tightly and specifically with a peptide representing the gH2AX C terminus and that binding is absolutely dependent on phosphorylation of Ser139, the ATM target site. Second, the X-ray structure of the MDC1-gH2AX complex reveals that the BRCT-domain binding cleft is exquisitely tailored to recognize the gH2AX motif and shows how the unusualand possibly unique-proximity of the Ser139Gln140 PIKK phosphorylation site to the H2AX C terminus is detected. Finally, we show that the major function of this interaction is to promote accumulation and prolonged interaction of DDR factors in damaged-chromatin regions, a process that appears to be essential for efficient and accurate DSB repair but not for checkpoint activation. Together, our data demonstrate clear in vivo relevance of the direct interaction between MDC1 and gH2AX and have important mechanistic, biological, and evolutionary implications for our understanding of DNA-damage-initiated events in the context of chromatin.
EXPERIMENTAL PROCEDURES
Plasmids MDC1 FHA-GST and MDC1 BRCT-GST were as described (Goldberg et al., 2003) . Full-length wild-type and DBRCT GFP-MDC1 constructs were from P.-L. Chen (Shang et al., 2003) . pSUPER-MDC1 and LacZ shRNA constructs have been described (Lukas et al., 2004) . Full-length MDC1 and BRCT-only T1898V, R1933Q, and K1936M mutants were generated by the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The YFP-BRCT construct comprised MDC1 residues 1883-2089 and a nuclear localization signal. To generate an inducible expression cassette, two tetracycline-repressor binding elements were inserted between promoter and coding sequences. The genomic fragment comprising the mouse H2AX coding and endogenous promoter sequences was a gift from A. Nussenzweig (Celeste et al., 2003b) .
Extract Preparation, Protein Expression, and Purification Whole-cell extracts were prepared in SDS sample buffer or buffer A (50 mM Tris-HCl [pH 7.5], 200 mM NaCl, 0.5% NP-40, 1 mM dithiothreitol, 1 mM AEBSF). HeLa and 293T nuclear cell extracts were purchased from Computer Cell Culture Center (HeLa) or prepared according to Dignam et al. (1983) . For H2AX peptide pull-downs, MDC1 BRCT domains were expressed as GST fusions in E. coli and purified on glutathione Sepharose (Amersham Pharmacia Biotech). For ITC and crystallization, proteins were synthesized in E. coli BL21 (Novagen) using the pGEX-4T1 vector (Amersham Pharmacia Biotech) by overnight shaking in LB at 18ºC and were purified by glutathione Sepharose affinity and S75 (Amersham Pharmacia Biotech) gel filtration chromatography following removal of glutathione S-transferase fusion with thrombin. MDC1 BRCT N-terminal limits were determined by Edman sequencing and electrospray mass spectrometry. Selenomethionine (SeMet) incorporated MDC1 BRCT was expressed in E. coli B834(DE3) cells (Novagen) and purified as for native protein.
Peptide Binding Synthetic peptides were from Dr. W. Mawby (University of Bristol). For pull-downs, biotinylated phosphopeptide (hH2AX 123-142) and its unphosphorylated derivative were coupled to streptavidin-coated Dynabeads M-280 (Dynal), incubated with HeLa or 293T nuclear extracts, and incubated with purified GST-BRCT fractions. Beads were washed extensively with Tris buffer saline (pH 7.5) containing 1% (v/v) Tween 20 and bound proteins subjected to SDS-PAGE and immunoblotting. Quantification of BRCT-phosphopeptide interaction was by ITC (Wiseman et al., 1989 ) with a MicroCal Omega VP-ITC calorimeter (MicroCal Inc., Northampton, MA). Proteins were dialyzed against ITC buffer (50 mM HEPES, 300 mM NaCl, 0.5 mM b-mercaptoethanol). Experiments were done at 20ºC and involved 30 successive 10 ml injections of 300-800 mM peptide solution into a sample cell containing 30-80 mM protein solution. Heats of dilution were subtracted and binding isotherms were plotted and analyzed with MicroCal Origin version 7.0, assuming a single-site binding model.
Peptide Library Binding
Peptide library binding was done essentially as described (Yaffe and Cantley, 2000) . For motif determination, a phosphoserine-oriented degenerate library of sequence KKKYAXXXXpSXXX (X denotes all amino acids except Cys) was synthesized. Screening was done with saturating amounts of GST-MDC1 BRCT (1-1.5 mg). Bound peptides were sequenced by automated Edman degradation on a Procise protein microsequencer. Selectivity values for each residue were determined by comparing the relative abundance (mole percentage) of each amino acid at a sequencing cycle in the recovered peptides to that of each amino acid in the original library mixture at the same position (Yaffe and Cantley, 2000) .
Crystallization and Structure Determination
Native and selenomethionine MDC1 BRCT (residues 1883-2089) were crystallized with a 1:2 stoichiometric excess of a doubly phosphorylated H2AX peptide (KKA-pT136-QA-pS139-QEY) by hanging-drop vapor diffusion at 18ºC. Crystals grew from 1 ml protein-phosphopeptide complex (0.66 mM) and 1 ml reservoir solution (35%-37% PEG 4K, 0.4 M NaCl, and 0.1 M Tris-HCl [pH 8.5]) in space group P2 1 2 1 2 1 (a = 67.4 Å , b = 75.6 Å , c = 114.9 Å ), with two molecules in the asymmetric unit. Crystals were dehydrated over a 50% w/v PEG 4K solution, equilibrated for 12 hr, and flash cooled directly from the mother liquor. Data from a single-wavelength anomalous dispersion experiment at the selenium edge were collected at the SRS Daresbury (Station 14.2) and processed using DENZO and SCALEPACK (Otwinowski and Minor, 1997) . Four selenium-atom positions were located and refined using SOLVE, giving a figure of merit of 0.3 (Terwilliger and Berendzen, 1999) . Phases were improved with RESOLVE (Terwilliger and Berendzen, 1999) , resulting in a readily interpretable electron density map that was further improved by noncrystallographic symmetry averaging in DM (Cowtan and Main, 1996) . Model building was carried out using O (Jones et al., 1991) , and the structure was refined at 2.4 Å using REFMAC5 (Murshudov et al., 1997) . Datacollection, phasing, and refinement statistics are summarized in Table  S1 of the Supplementat Data. All structure figures were prepared with Pymol (http://pymol.sourceforge.net/).
Cell Culture
Transfection of plasmids and siRNAs was with FuGene6 (Roche) or calcium phosphate and Oligofectamine (Invitrogen), respectively. Luciferase (CGUACGCGGAAUACUUCGAdTdT) and MDC1-targeting (GUCUCC CAGAAGACAGUGUdTdT) siRNA duplexes were from Dharmacon. Inhibitors of ATM (KU55933) (Hickson et al., 2004) and DNA-PKcs (NU7026) (Veuger et al., 2004) were used at 10 mM (gift from G. Smith). Complementation of H2AX ÿ/ÿ p53 ÿ/ÿ MEFs was as described (Celeste et al., 2003b) . Stable downregulation of MDC1 was as described (Lukas et al., 2004) . Inducible YFP-BRCT-expressing cells were generated by transfection of a U2OS cell line expressing the tetracycline repressor (Invitrogen) with inducible YFP-BRCT expression plasmid encoding wildtype MDC1 BRCT domains or K1936M mutant followed by selection with neomycin (G418). Irradiation was done in a Faxitron X-ray cabinet at 3.15 Gy/min. Clonogenic survival and RDS assays were as described (Falck et al., 2005; Goldberg et al., 2003) . Random plasmid integration was done by transfection of linearized pBabe-puro with LacZ expression plasmid. Twenty-four hours later, cells were replated at low density in puromycine-containing medium. and colonies were counted 10 days after transfection. A fraction of the transfected cells were stained with X-Gal to normalize for transfection efficiency.
Antibodies and Immunofluorescence
Commercial antibodies used in this study were from Abcam (Chk2 and tubulin), Novus Biologicals (ATM and 53PB1), Upstate (gH2AX and H2A), Rockland Immunochemicals (pS1981-ATM), Bethyl Laboratories (H2AX, pS966-SMC1, and SMC1), Cell Signaling Technology (pS1981-ATM, pT68-Chk2, pS15-p53, pS343-Nbs1, and p53), Oncogene (Nbs1 and DNA-PKcs), BD Biosciences (YFP), Serotec (Ku70), and Santa Cruz Biotechnology (BRCA1). Monoclonal anti-GFP antibody was from Cancer Research UK. Rabbit and sheep antisera to MDC1, RAD50, NBS1, and MRE11 and rabbit antiserum for mouse MDC1 have been described (Goldberg et al., 2003; Lee et al., 2005) . Purified sheep antibodies to human PTIP were from J. Rouse (Jowsey et al., 2004) , and rabbit antiserum to mouse NBS1 was from A. Nussenzweig (Celeste et al., 2003b) . For immunofluorescence staining, cells were grown on glass coverslips and fixed in ice-cold methanol or methanol/acetone.
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